News
-
GSK Consumer Healthcare has announced that Children’s Flonase fluticasone propionate nasal spray is now available over the counter in the US. The FDA approved OTC sales of Flonase in July 2014, and the product has… Read more . . .
-
Sunovion is presenting observational study data at the Hospital Medicine 2016 conference showing that a substantial number of COPD patients are discharged from hospitals with a prescription for a dry powder inhaler despite their inability… Read more . . .
-
Boehringer Ingelheim has presented data at the 2016 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting showing that the Spiriva Respimat tiotropium bromide soft mist inhaler improves lung function and reduces exacerbations when… Read more . . .
-
Powder testing specialist Freeman Technology has announced that Managing Director Tim Freeman has received the Richard S. Ladd Standards Development Award from the ASTM for development of ASTM Standard Designation D7891 “Standard Test Method for… Read more . . .
-
Australian medical cannabis company MGC Pharmaceuticals has signed a collaboration agreement with Israeli device developer SipNose for development of a cannabinoid therapy for the treatment of epilepsy, the company said. The agreement includes an option… Read more . . .
-
A study published in the British Journal of General Practice titled “Overdiagnosis of asthma in children in primary care: a retrospective analysis” found that over half of children diagnosed with asthma at several major healthcare… Read more . . .
-
Savara Pharmaceuticals has announced the completion of a $20 million financing round to fund a pivotal Phase 3 clinical trial of its AeroVanc vancomycin DPI for the treatment of MRSA lung infections in cystic fibrosis… Read more . . .
-
Intranasal delivery specialist Impel NeuroPharma and the Toronto-based Centre for Addiction and Mental Health (CAMH) have signed a licensing agreement for an intranasal neuropeptide-based therapy for the treatment of depression. The peptide, which was discovered… Read more . . .
-
Inhaled drug developer Alexza Pharmaceuticals has signed a non-binding letter of intent and entered into discussions with Grupo Ferrer regarding Ferrer’s acquisition offer, the company said. Alexza noted that the letter of intent allows the… Read more . . .
-
MannKind Corporation has announced the death of founder and Chairman Emeritus Alfred Mann at age 90, one week after he stepped down as Chairman of the Board. Mann served as CEO from November 2003 until… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
No events are found.